Recent Press Releases

iBio, Inc. and GE Healthcare form new global alliance

iBio, Inc. and GE Healthcare form new global alliance --Companies to commercialize plant-based technologies for biopharmaceutical and vaccine manufacture --Innovative approach offers potential to...

New public-private partnership, CHAIT initiative, focuses on the development of novel immunological therapeutic interventions to achieve functional HIV cure HIV Functional Cure Symposium

New public-private partnership, CHAIT initiative, focuses on the development of novel immunological therapeutic interventions to achieve functional HIV cure HIV Functional Cure Symposium WASHINGTON,...

Vaxil BioTherapeutics completed the merger of its activities with Sheldonco Ltd

Vaxil BioTherapeutics completed the merger of its activities with Sheldonco Ltd Nes-Ziona, Israel – July, 2012 – Vaxil BioTherapeutics (SLDC:IT), a clinical stage biotechnology company...

Sanofi Pasteur's Dengue Vaccine Demonstrates Proof of Efficacy

Sanofi Pasteur's Dengue Vaccine Demonstrates Proof of Efficacy July 25, 2012 - Early data analysis confirms excellent safety profile and shows vaccine ability to protect against disease caused by...

Researchers Study Vaccine Created from Patient Blood Cells as Potential Weapon Against Aggressive Brain Tumors

Researchers Study Vaccine Created from Patient Blood Cells as Potential Weapon Against Aggressive Brain Tumors CHICAGO, July 24, 2012 Northwestern Brain Tumor Institute participates in national...

Medicago Successfully Completes the Production of More Than Ten Million Doses of H1N1 VLP Influenza Vaccine in One Month

Medicago Successfully Completes the Production of More Than Ten Million Doses of H1N1 VLP Influenza Vaccine in One Month DURHAM, NC and QUEBEC CITY, QC, July 24, 2012 -- Medicago Inc. CA:MDG +5.88%...

Pitt Scientists Developing Universal Flu Vaccine in Partnership with Sanofi Pasteur

Pitt Scientists Developing Universal Flu Vaccine in Partnership with Sanofi Pasteur PITTSBURGH, July 19, 2012 – A vaccine strategy that protects against all strains of seasonal influenza and...

Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients

Phase 3 Clinical Trial of GSK's Herpes Zoster Vaccine Candidate Containing Agenus' QS-21 Commences in Immunocompromised Patients LEXINGTON, Mass., July 18, 2012 (GLOBE NEWSWIRE) -- Agenus,...

Galena Biopharma Issued NeuVax(TM) U.S. Patent

Galena Biopharma Issued NeuVax(TM) U.S. Patent Patent strengthens NeuVax Intellectual Property position for treating Phase 3 target population of low-to-intermediate (IHC 1+/2+) HER2 patients....

U.S. Government Expands Population Eligible to Receive Bavarian Nordic's Smallpox Vaccine in an Emergency

U.S. Government Expands Population Eligible to Receive Bavarian Nordic's Smallpox Vaccine in an Emergency Wed Jul 11, 2012 2:01am EDT People with Atopic Dermatitis and HIV Now Eligible to...

Early shipments of flu vaccine allow health care providers to begin immunization and clinic plans with confidence in vaccine supply

Early shipments of flu vaccine allow health care providers to begin immunization and clinic plans with confidence in vaccine supply - SWIFTWATER, Pa., July 9, 2012-- Sanofi Pasteur, the vaccines...

New research study explores attitudes to polio immunisation in India

New research study explores attitudes to polio immunisation in India Posted on Friday 13th July 2012 The University of Birmingham is working with Ravenshaw University in Orissa on a new research...

CSL Biotherapies provides update on Fluvax® investigation

CSL Biotherapies provides update on Fluvax® investigation Melbourne, Australia — 20/06/2012 CSL Biotherapies (CSL) today presented preliminary conclusions from its investigations into the...

NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India

NOVAVAX, CPL Biologicals and the International Centre for Genetic Engineering and Biotechnology Announce Collaboration to Develop New Malaria Vaccine With Funding From Government of India ROCKVILLE,...

NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery

NIH Awards $31 Million for HIV/AIDS Vaccine Immunology and Immunogen Discovery Duke University and Scripps Research Institute to Lead New Consortium Duke University of Durham, N.C., and the Scripps...

Overweight? There's a vaccine for that

Overweight? There's a vaccine for that New vaccines promote weight loss. A new study, published in BioMed Central's open access journal, Journal of Animal Science and Biotechnology, assesses...

GLOBVAC Awards Bionor Pharma US$1.7 Million to Advance Research Towards an HIV Cure Using Vaccine Vacc-4x

GLOBVAC Awards Bionor Pharma US$1.7 Million to Advance Research Towards an HIV Cure Using Vaccine Vacc-4x Award Represents Vital Step to Research Future Solutions for People Living With HIV OSLO,...

BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa

BWH researchers discover new vaccine candidate for Pseudomonas aeruginosa BOSTON, MA—Researchers at Brigham and Women's Hospital (BWH) have discovered a new vaccine candidate for the...

PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine

PsiOxus Therapeutics Secures £22 Million ($34 Million) in Series B Financing to Drive Clinical Development for Oncolytic Vaccine Investment to Advance ColoAd1 through Phase II Clinical Trial...

Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease.

Scientists at the University of North Carolina School of Medicine have used injections of antibodies to rapidly reverse the onset of Type I diabetes in mice genetically bred to develop the disease. ...